The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Genzyme Corp.  (GENZ) Trade Now »     Rate GENZ  -  Discuss GENZ  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks
This Quarter's Sentiment:
All:
93.5%
Top:
100.0%
Rate GENZ:



GENZ Analysis & Videos »


GENZ: Bull or Bear?

BioMed News Bytes: Genzyme, OSI Pharma, Pfizer, Seattle Genetics Graphic_rating_buy GENZ
Mikerun
73%
+0.78%
in 9 days
By  Mike Havrilla   (+1.04%  risk: conservative)  11/16/09 Comment


Genzyme: Up ahead, an uptrend Graphic_rating_buy GENZ
-10.97%
in 44 days
By  Joseph Lazzaro   (+1.63%  risk: moderate)  10/12/09 Comment


Genzyme: Robust Growth Prospects at Clearance Sale Prices Graphic_rating_buy GENZ
Mikerun
73%
+3.73%
in 101 days
(closed on 11/16/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  08/07/09 Comment


Get free stock alert for GENZ:
Your Email Address:


FDA Calendar Updates: Genzyme FDA Woes Benefit Protalix, Shire Graphic_rating_buy GENZ
Mikerun
73%
-6.79%
in 7 days
(closed on 08/07/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  07/31/09 Comment


FDA, Clinical Trial Updates: GENZ, HGSI, LLY, NGSX Graphic_rating_buy GENZ
Mikerun
73%
-11.86%
in 71 days
(closed on 07/31/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  05/21/09 Comment


FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson Graphic_rating_buy GENZ
Mikerun
73%
+12.12%
in 29 days
(closed on 05/21/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  04/22/09 Comment


Highly Defensive Index: Opportunities in Healthcare Graphic_rating_buy GENZ
Mikerun
73%
-6.57%
in 9 days
(closed on 04/22/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  04/13/09 Comment


EXACT Sciences Announces New Management Team Graphic_rating_buy GENZ
Mikerun
73%
-2.10%
in 26 days
(closed on 04/13/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  03/18/09 Comment


Get free stock alert for GENZ:
Your Email Address:


Updated Clinical Trial and FDA Decision Calendars Graphic_rating_buy GENZ
Mikerun
73%
-20.30%
in 24 days
(closed on 03/18/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  02/22/09 Comment


Healthcare Investing Trends in '09 and Beyond Graphic_rating_buy GENZ
Mikerun
73%
+0.83%
in 15 days
(closed on 02/22/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  02/07/09 Comment


EXACT Sciences Forms Pact with Genzyme Graphic_rating_buy GENZ
Mikerun
73%
+2.23%
in 10 days
(closed on 02/07/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  01/28/09 Comment


Index to Track New Era for Stem Cell Cos. Graphic_rating_buy GENZ
Mikerun
73%
+3.26%
in 5 days
(closed on 01/28/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  01/23/09 Comment


Calendar of 163 FDA Decisions and Clinical Trials Graphic_rating_buy GENZ
Mikerun
73%
-2.92%
in 2 days
(closed on 01/23/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  01/21/09 Comment


FDA Decision Date Calendar Graphic_rating_buy GENZ
Mikerun
73%
+10.29%
in 8 days
(closed on 01/21/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  01/13/09 Comment


FDA Calendar: Allergan's New Rx for Eyelashes Graphic_rating_buy GENZ
Mikerun
73%
-5.02%
in 15 days
(closed on 01/13/09)
By  Mike Havrilla   (+1.04%  risk: conservative)  12/28/08 Comment





People Bullish on GENZ

Mikerun
Mike Havrilla
Principal
73%
8 days ago

Joseph Lazzaro
Tracked Blogger
43%
about 1 mo ago

mauskar12
Analyst
N/A
about 1 mo ago

mrkennel
Analyst
N/A
about 1 mo ago

hadramout
Analyst
N/A
3 mos ago


People Bearish on GENZ

sdepatie
Analyst
N/A
19 days ago

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.37% 379
2 18.14 +70.70% 210
3 17.66 +25.67% 55
4 13.47 +14.32% 61
5 12.13 +78.05% 39


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on GENZ


Discussion Wall + Add  

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies

128_by_128_cp
Contrarian Profits   (-2.33%  risk: conservative)
3 Clean Energy Stocks For An Obama Presidency How will the stock markets respond to a new US president? Martin Delholm says the impact will be less than some people expect. But some sectors will be...
+   0 replies


More Resources

Graphic_arrow1 About Genzyme Corp. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch